Lipid-lowering agents (statins)
- First-line LDL lowering / ASCVD prevention
- Atorvastatin/rosuvastatin: high-intensity tools
- Proven MI/stroke/mortality benefit
- Myalgia common; rhabdomyolysis rare
- Small diabetes-risk increase
- CYP3A DDIs: simvastatin/lovastatin
- Add ezetimibe/PCSK9 if LDL remains high
Class at a glance
- First-line LDL lowering / ASCVD prevention
Pharmacology
- CYP3A DDIs: simvastatin/lovastatin
Members / distinctions
- Atorvastatin/rosuvastatin: high-intensity tools
- Proven MI/stroke/mortality benefit
- Myalgia common; rhabdomyolysis rare
- Add ezetimibe/PCSK9 if LDL remains high
Safety / monitoring
- Small diabetes-risk increase
Self-check
- Which drug class is first-line for LDL lowering / ASCVD prevention?
Lipid-lowering agents (statins).
Drugs in this class (7)
All drug classes · Open the interactive console ↗
